Novartis
NVS
NVS
1,089 hedge funds and large institutions have $21.2B invested in Novartis in 2019 Q3 according to their latest regulatory filings, with 71 funds opening new positions, 356 increasing their positions, 446 reducing their positions, and 69 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
less ownership
Funds ownership: →
10% less capital invested
Capital invested by funds: $23.5B → $21.2B (-$2.26B)
20% less repeat investments, than reductions
Existing positions increased: 356 | Existing positions reduced: 446
52% less funds holding in top 10
Funds holding in top 10: 29 → 14 (-15)
Holders
1,089
Holding in Top 10
14
Calls
$162M
Puts
$154M
Top Buyers
| 1 | +$98.7M | |
| 2 | +$68.9M | |
| 3 | +$59.7M | |
| 4 |
SC
Sculptor Capital
New York
|
+$28.5M |
| 5 |
Jennison Associates
New York
|
+$28.3M |
Top Sellers
| 1 | -$250M | |
| 2 | -$231M | |
| 3 | -$175M | |
| 4 |
Franklin Resources
San Mateo,
California
|
-$137M |
| 5 |
BBHC
Brown Brothers Harriman & Co
New York
|
-$105M |